Let’s use Keytruda (pembrolizumab) as an example… it is an FDA-approved immunotherapy drug used to treat several cancers, including melanoma, lung, bladder, head and neck, breast, and colorectal cancers. Average cost: around $11,000–$13,000 per dose (given every 3–6 weeks) It’s a PD-1 checkpoint inhibitor that blocks the PD-1 receptor on immune cells, releasing the immune “brakes” so T-cells can attack cancer cells that hide from detection. 🤷🏼‍♀️Common side effects: fatigue, nausea, rash, join
FacebookLaura Ramos
Let’s use Keytruda (pembrolizumab) as an example… it is an FDA-approved immunotherapy drug used to treat several cancers, including melanoma, lung, bladder, head and neck,
Laura Ramos. Laura Ramos · Original audio. Let’s use Keytruda (pembrolizumab) as an example… it is an FDA-approved immunotherapy drug used to treat several cancers, including melanoma, lung, bladder, head and neck, breast, and colorectal cancers. Average cost: around $11,000–$13,000 per dose (given every 3–6 weeks) It’s a PD-1 ...
1.7K views7 months ago
Pembrolizumab Side Effects
Pembrolizumab (Keytruda): How It Works, Side Effects & What Patients Should Know
14:04
Pembrolizumab (Keytruda): How It Works, Side Effects & What Patients Should Know
YouTubeDEMIRxCARE
54 views4 months ago
💊What is PEMBROLIZUMAB?. Mechanism of Action, Dosage and Side Effects of Pembrolizumab (KEYTRUDA)💊
13:24
💊What is PEMBROLIZUMAB?. Mechanism of Action, Dosage and Side Effects of Pembrolizumab (KEYTRUDA)💊
YouTubeMedicines/Diseases
1.6K viewsJun 4, 2020
Keytruda (pembrolizumab) Benefits & Side effects
1:19
Keytruda (pembrolizumab) Benefits & Side effects
YouTubeariflive
40 views11 months ago
Top videos
FDA approves Keytruda (pembrolizumab) and Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph), each with Padcev (enfortumab vedotin-ejfv)
FDA approves Keytruda (pembrolizumab) and Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph), each with Padcev (enfortumab vedotin-ejfv)
marketscreener.com
6 months ago
2026 ASCO GU Highlights: Bladder Cancer KEYNOTE-B15 | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
2:57
2026 ASCO GU Highlights: Bladder Cancer KEYNOTE-B15 | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
targetedonc.com
3 months ago
Enfortumab vedotin and pembrolizumab improves EFS, OS, and pCR in muscle-invasive bladder cancer
4:34
Enfortumab vedotin and pembrolizumab improves EFS, OS, and pCR in muscle-invasive bladder cancer
YouTubeecancer
2 weeks ago
Pembrolizumab for Lung Cancer
PD-L1, PD1,TMB and Lung Cancer
PD-L1, PD1,TMB and Lung Cancer
lung.org
5 months ago
In 2017, Oswald was diagnosed with stage 4 non-small cell lung cancer. After just two infusions of the immunotherapy checkpoint inhibitor, Keytruda (pembrolizumab), scans showed that the cancer had shrunk dramatically. Watch Oswald's full story here: https://youtu.be/_FACxuC9czs | Cancer Research Institute
0:15
In 2017, Oswald was diagnosed with stage 4 non-small cell lung cancer. After just two infusions of the immunotherapy checkpoint inhibitor, Keytruda (pembrolizumab), scans showed that the cancer had shrunk dramatically. Watch Oswald's full story here: https://youtu.be/_FACxuC9czs | Cancer Research Institute
FacebookCancer Research Institute
221 views5 months ago
Immune System Modulators to Treat Cancer
Immune System Modulators to Treat Cancer
cancer.gov
Sep 24, 2019
FDA approves Keytruda (pembrolizumab) and Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph), each with Padcev (enfortumab vedotin-ejfv)
FDA approves Keytruda (pembrolizumab) and Keytruda Ql…
6 months ago
marketscreener.com
2026 ASCO GU Highlights: Bladder Cancer KEYNOTE-B15 | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
2:57
2026 ASCO GU Highlights: Bladder Cancer KEYNOTE-B15 | Targeted …
3 months ago
targetedonc.com
Enfortumab vedotin and pembrolizumab improves EFS, OS, and pCR in muscle-invasive bladder cancer
4:34
Enfortumab vedotin and pembrolizumab improves EFS, OS…
2 weeks ago
YouTubeecancer
Leslie Ballas, MD, highlights trial of risk-adapted bladder preservation in MIBC
2:59
Leslie Ballas, MD, highlights trial of risk-adapted bladder preservation …
73 views2 months ago
YouTubeUrology Times
Pembrolizumab alone achieves bladder preservation and ctDNA predicts outcomes in muscle-Invasive...
6:00
Pembrolizumab alone achieves bladder preservation and ctDNA p…
2 weeks ago
YouTubeecancer
Understanding Keytruda Cancer Treatment Mechanism
Understanding Keytruda Cancer Treatment Mechanism
34.9K viewsJan 28, 2025
TikTokscientistswanda
Choosing Between Atezolizumab and Pembrolizumab in Lung Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Choosing Between Atezolizumab and Pembrolizumab in Lung Canc…
Jul 2, 2018
targetedonc.com
6:11
Pembrolizumab: Monotherapy Versus Combination Therapy
768 viewsJun 29, 2018
YouTubeOncLive
2:55
How Keytruda Cancer Treatment Works (Update)
86.1K viewsOct 15, 2018
YouTubeLighter Side of Cancer
19:21
Immunotherapy for Muscle Invasive Bladder Cancer
2.7K viewsNov 17, 2020
YouTubeGrand Rounds in Urology
4:46
Cholinergic Drugs - Pharmacology, Animation
401.1K viewsJun 9, 2020
YouTubeAlila Medical Media
3:20
How Monoclonal Antibodies Treat Cancer
177.2K viewsJun 30, 2020
YouTubeNational Cancer Institute
1:16
Explaining Immunotherapy, PD-L1 and PD-1
40.5K viewsSep 14, 2020
YouTubeAmerican Lung Association
0:10
Laura Ramos I Self-healing Advocate 🌱 on Instagram: "Let’s us…
5.5K views7 months ago
Instagramlaurae_ramos
3:12
Opdivo (nivolumab) the Immunotherapy Cancer Treatment
80.6K viewsJun 3, 2016
YouTubeOncology Associates
5:05
Anti-HER2 Mechanisms of Approved HER2 Inhibitors
166.8K viewsApr 30, 2013
YouTubeHMP Global
8:39
How Does Furosemide Work? Understanding Loop Diuretics
331K viewsJan 17, 2019
YouTubeZero To Finals
2:40
Drug treatment for overactive bladder
118.5K viewsJan 29, 2018
YouTubeEuropean Association of Urology
2:05
Pembrolizumab as Second-line Therapy for Advanced Urothelial C…
11.5K viewsMar 16, 2017
YouTubeNEJM Group
5:14
Olaparib and Keytruda For Advanced Prostate Cancer | | Lear…
3.6K viewsJan 8, 2020
YouTubeProstate Cancer Research Institute
1:51
Checkpoint Inhibitors: Taking the Brakes Off the Immune System
148.6K viewsJun 19, 2015
YouTubeCancer Research Institute
2:47
The Mechanism of Action of Immunotherapy for Cancer Treatm…
22.3K viewsJul 30, 2020
YouTubeScientific Animations
2:39
Enfortumab Vedotin Approved by FDA for Patients With Refractory …
388 viewsJan 10, 2020
YouTubeGrand Rounds in Urology
8:07
Long term outcome of enfortumab vedotin + pembrolizumab in first li…
907 viewsAug 3, 2021
YouTubeecancer
13:24
💊What is PEMBROLIZUMAB?. Mechanism of Action, Dosage an…
1.6K viewsJun 4, 2020
YouTubeMedicines/Diseases
24:15
Bladder Cancer and Immunotherapy
744 viewsApr 22, 2019
YouTubeGrand Rounds in Urology
2:38
How Cancer Drug Keytruda ( Pembrolizumab) Treats Melanoma
11.1K viewsOct 27, 2017
YouTubeLighter Side of Cancer
1:46
Pembrolizumab
6K viewsJan 30, 2019
YouTubeThe Ruesch Center
15:09
PEMBROLIZUMAB | KEYTRUDA En Español
5.4K viewsJun 7, 2020
YouTubeMedicines/Diseases
See more videos
Static thumbnail place holder